nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemcitabine—kidney cancer—melanoma	0.314	0.509	CtDrD
Gemcitabine—lung cancer—melanoma	0.303	0.491	CtDrD
Gemcitabine—ABCB1—melanoma	0.0703	1	CbGaD
Gemcitabine—ABCC10—Docetaxel—melanoma	0.0671	0.785	CbGbCtD
Gemcitabine—ABCB1—Dactinomycin—melanoma	0.0121	0.142	CbGbCtD
Gemcitabine—ABCB1—Docetaxel—melanoma	0.00625	0.0732	CbGbCtD
Gemcitabine—CMPK1—hair follicle—melanoma	0.00223	0.0795	CbGeAlD
Gemcitabine—POLD1—neck—melanoma	0.00188	0.0669	CbGeAlD
Gemcitabine—RRM1—hair follicle—melanoma	0.00143	0.051	CbGeAlD
Gemcitabine—TYMS—Paclitaxel—Docetaxel—melanoma	0.00129	1	CbGdCrCtD
Gemcitabine—POLD1—skin of body—melanoma	0.00121	0.0433	CbGeAlD
Gemcitabine—SLC28A3—mammalian vulva—melanoma	0.00102	0.0362	CbGeAlD
Gemcitabine—CDA—mammalian vulva—melanoma	0.000994	0.0354	CbGeAlD
Gemcitabine—CMPK1—skin of body—melanoma	0.000969	0.0345	CbGeAlD
Gemcitabine—POLA1—retina—melanoma	0.000891	0.0318	CbGeAlD
Gemcitabine—POLE—mammalian vulva—melanoma	0.000828	0.0295	CbGeAlD
Gemcitabine—POLD1—head—melanoma	0.000792	0.0282	CbGeAlD
Gemcitabine—RRM2—skin of body—melanoma	0.000747	0.0266	CbGeAlD
Gemcitabine—RRM1—eye—melanoma	0.000714	0.0254	CbGeAlD
Gemcitabine—POLA1—mammalian vulva—melanoma	0.000713	0.0254	CbGeAlD
Gemcitabine—RRM1—retina—melanoma	0.000707	0.0252	CbGeAlD
Gemcitabine—RRM2—mammalian vulva—melanoma	0.000682	0.0243	CbGeAlD
Gemcitabine—CMPK1—head—melanoma	0.000632	0.0225	CbGeAlD
Gemcitabine—RRM1—skin of body—melanoma	0.000621	0.0221	CbGeAlD
Gemcitabine—POLE—head—melanoma	0.000592	0.0211	CbGeAlD
Gemcitabine—RRM1—mammalian vulva—melanoma	0.000566	0.0202	CbGeAlD
Gemcitabine—TYMS—skin of body—melanoma	0.000563	0.0201	CbGeAlD
Gemcitabine—POLD1—lymph node—melanoma	0.000555	0.0198	CbGeAlD
Gemcitabine—DCK—retina—melanoma	0.000549	0.0196	CbGeAlD
Gemcitabine—TYMS—mammalian vulva—melanoma	0.000513	0.0183	CbGeAlD
Gemcitabine—CDA—lymph node—melanoma	0.000498	0.0177	CbGeAlD
Gemcitabine—RRM2—head—melanoma	0.000488	0.0174	CbGeAlD
Gemcitabine—SLC29A2—lymph node—melanoma	0.000465	0.0166	CbGeAlD
Gemcitabine—SLC29A1—mammalian vulva—melanoma	0.00046	0.0164	CbGeAlD
Gemcitabine—CMPK1—lymph node—melanoma	0.000443	0.0158	CbGeAlD
Gemcitabine—DCK—mammalian vulva—melanoma	0.00044	0.0157	CbGeAlD
Gemcitabine—ABCC10—mammalian vulva—melanoma	0.000419	0.0149	CbGeAlD
Gemcitabine—POLE—lymph node—melanoma	0.000415	0.0148	CbGeAlD
Gemcitabine—RRM1—head—melanoma	0.000405	0.0144	CbGeAlD
Gemcitabine—TYMS—head—melanoma	0.000367	0.0131	CbGeAlD
Gemcitabine—POLA1—lymph node—melanoma	0.000357	0.0127	CbGeAlD
Gemcitabine—RRM2—lymph node—melanoma	0.000341	0.0122	CbGeAlD
Gemcitabine—SLC29A1—head—melanoma	0.000329	0.0117	CbGeAlD
Gemcitabine—DCK—head—melanoma	0.000315	0.0112	CbGeAlD
Gemcitabine—ABCB1—blood vessel—melanoma	0.000287	0.0102	CbGeAlD
Gemcitabine—RRM1—lymph node—melanoma	0.000284	0.0101	CbGeAlD
Gemcitabine—TYMS—lymph node—melanoma	0.000257	0.00917	CbGeAlD
Gemcitabine—SLC29A1—lymph node—melanoma	0.000231	0.00822	CbGeAlD
Gemcitabine—DCK—lymph node—melanoma	0.00022	0.00786	CbGeAlD
Gemcitabine—ABCC10—lymph node—melanoma	0.00021	0.00748	CbGeAlD
Gemcitabine—Constipation—Vemurafenib—melanoma	0.000197	0.00196	CcSEcCtD
Gemcitabine—Pancytopenia—Temozolomide—melanoma	0.000197	0.00196	CcSEcCtD
Gemcitabine—Haemorrhage—Bleomycin—melanoma	0.000196	0.00196	CcSEcCtD
Gemcitabine—Pulmonary oedema—Docetaxel—melanoma	0.000195	0.00195	CcSEcCtD
Gemcitabine—Neutropenia—Temozolomide—melanoma	0.000194	0.00193	CcSEcCtD
Gemcitabine—Hyperglycaemia—Carmustine—melanoma	0.000193	0.00193	CcSEcCtD
Gemcitabine—Pneumonia—Carmustine—melanoma	0.000192	0.00191	CcSEcCtD
Gemcitabine—Agranulocytosis—Dactinomycin—melanoma	0.00019	0.0019	CcSEcCtD
Gemcitabine—Sepsis—Docetaxel—melanoma	0.00019	0.0019	CcSEcCtD
Gemcitabine—Renal failure—Carmustine—melanoma	0.000188	0.00187	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Carmustine—melanoma	0.000187	0.00187	CcSEcCtD
Gemcitabine—Hyperglycaemia—Temozolomide—melanoma	0.000187	0.00186	CcSEcCtD
Gemcitabine—Stomatitis—Carmustine—melanoma	0.000186	0.00186	CcSEcCtD
Gemcitabine—Pneumonia—Temozolomide—melanoma	0.000186	0.00185	CcSEcCtD
Gemcitabine—Blood alkaline phosphatase increased—Docetaxel—melanoma	0.000183	0.00183	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000183	0.00182	CcSEcCtD
Gemcitabine—Body temperature increased—Vemurafenib—melanoma	0.000182	0.00181	CcSEcCtD
Gemcitabine—Pharyngitis—Dactinomycin—melanoma	0.000182	0.00181	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Temozolomide—melanoma	0.000181	0.0018	CcSEcCtD
Gemcitabine—Stomatitis—Temozolomide—melanoma	0.00018	0.00179	CcSEcCtD
Gemcitabine—Deafness—Docetaxel—melanoma	0.000178	0.00177	CcSEcCtD
Gemcitabine—Hepatic failure—Docetaxel—melanoma	0.000177	0.00177	CcSEcCtD
Gemcitabine—Chills—Bleomycin—melanoma	0.000176	0.00176	CcSEcCtD
Gemcitabine—Cardiac failure congestive—Docetaxel—melanoma	0.000176	0.00175	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Temozolomide—melanoma	0.000175	0.00174	CcSEcCtD
Gemcitabine—Alopecia—Bleomycin—melanoma	0.000174	0.00173	CcSEcCtD
Gemcitabine—Erythema multiforme—Dactinomycin—melanoma	0.000173	0.00173	CcSEcCtD
Gemcitabine—Haemoglobin—Carmustine—melanoma	0.000172	0.00172	CcSEcCtD
Gemcitabine—Haemorrhage—Carmustine—melanoma	0.000171	0.00171	CcSEcCtD
Gemcitabine—Erythema—Bleomycin—melanoma	0.000171	0.0017	CcSEcCtD
Gemcitabine—Oedema peripheral—Carmustine—melanoma	0.000169	0.00168	CcSEcCtD
Gemcitabine—Connective tissue disorder—Carmustine—melanoma	0.000168	0.00168	CcSEcCtD
Gemcitabine—Renal impairment—Docetaxel—melanoma	0.000167	0.00167	CcSEcCtD
Gemcitabine—Dermatitis bullous—Docetaxel—melanoma	0.000167	0.00166	CcSEcCtD
Gemcitabine—Haemoglobin—Temozolomide—melanoma	0.000166	0.00166	CcSEcCtD
Gemcitabine—Haemorrhage—Temozolomide—melanoma	0.000166	0.00165	CcSEcCtD
Gemcitabine—Asthenia—Vemurafenib—melanoma	0.000165	0.00165	CcSEcCtD
Gemcitabine—Pharyngitis—Temozolomide—melanoma	0.000164	0.00164	CcSEcCtD
Gemcitabine—Chills—Dactinomycin—melanoma	0.000164	0.00164	CcSEcCtD
Gemcitabine—Urinary tract disorder—Temozolomide—melanoma	0.000164	0.00163	CcSEcCtD
Gemcitabine—Oedema peripheral—Temozolomide—melanoma	0.000163	0.00163	CcSEcCtD
Gemcitabine—Cardiac failure—Docetaxel—melanoma	0.000163	0.00163	CcSEcCtD
Gemcitabine—Pruritus—Vemurafenib—melanoma	0.000163	0.00162	CcSEcCtD
Gemcitabine—Connective tissue disorder—Temozolomide—melanoma	0.000163	0.00162	CcSEcCtD
Gemcitabine—Urethral disorder—Temozolomide—melanoma	0.000162	0.00162	CcSEcCtD
Gemcitabine—Alopecia—Dactinomycin—melanoma	0.000162	0.00161	CcSEcCtD
Gemcitabine—Erythema—Dactinomycin—melanoma	0.000159	0.00159	CcSEcCtD
Gemcitabine—Ill-defined disorder—Bleomycin—melanoma	0.000159	0.00158	CcSEcCtD
Gemcitabine—Anaemia—Bleomycin—melanoma	0.000158	0.00158	CcSEcCtD
Gemcitabine—Diarrhoea—Vemurafenib—melanoma	0.000158	0.00157	CcSEcCtD
Gemcitabine—Erythema multiforme—Temozolomide—melanoma	0.000157	0.00156	CcSEcCtD
Gemcitabine—Malaise—Bleomycin—melanoma	0.000154	0.00154	CcSEcCtD
Gemcitabine—Cardiac disorder—Temozolomide—melanoma	0.000154	0.00153	CcSEcCtD
Gemcitabine—Arrhythmia—Carmustine—melanoma	0.000153	0.00153	CcSEcCtD
Gemcitabine—Leukopenia—Bleomycin—melanoma	0.000153	0.00153	CcSEcCtD
Gemcitabine—Alopecia—Carmustine—melanoma	0.000151	0.00151	CcSEcCtD
Gemcitabine—ABCB1—retina—melanoma	0.000151	0.00539	CbGeAlD
Gemcitabine—Angiopathy—Temozolomide—melanoma	0.00015	0.0015	CcSEcCtD
Gemcitabine—Immune system disorder—Temozolomide—melanoma	0.00015	0.00149	CcSEcCtD
Gemcitabine—Mediastinal disorder—Temozolomide—melanoma	0.000149	0.00149	CcSEcCtD
Gemcitabine—Erythema—Carmustine—melanoma	0.000149	0.00149	CcSEcCtD
Gemcitabine—Cough—Bleomycin—melanoma	0.000149	0.00149	CcSEcCtD
Gemcitabine—Chills—Temozolomide—melanoma	0.000149	0.00148	CcSEcCtD
Gemcitabine—Ill-defined disorder—Dactinomycin—melanoma	0.000148	0.00147	CcSEcCtD
Gemcitabine—Anaemia—Dactinomycin—melanoma	0.000147	0.00147	CcSEcCtD
Gemcitabine—Liver function test abnormal—Docetaxel—melanoma	0.000147	0.00147	CcSEcCtD
Gemcitabine—Vomiting—Vemurafenib—melanoma	0.000146	0.00146	CcSEcCtD
Gemcitabine—Alopecia—Temozolomide—melanoma	0.000146	0.00146	CcSEcCtD
Gemcitabine—Myalgia—Bleomycin—melanoma	0.000146	0.00145	CcSEcCtD
Gemcitabine—Chest pain—Bleomycin—melanoma	0.000146	0.00145	CcSEcCtD
Gemcitabine—Rash—Vemurafenib—melanoma	0.000145	0.00145	CcSEcCtD
Gemcitabine—Dermatitis—Vemurafenib—melanoma	0.000145	0.00145	CcSEcCtD
Gemcitabine—Back pain—Carmustine—melanoma	0.000144	0.00144	CcSEcCtD
Gemcitabine—Headache—Vemurafenib—melanoma	0.000144	0.00144	CcSEcCtD
Gemcitabine—Erythema—Temozolomide—melanoma	0.000144	0.00144	CcSEcCtD
Gemcitabine—Discomfort—Bleomycin—melanoma	0.000144	0.00143	CcSEcCtD
Gemcitabine—Malaise—Dactinomycin—melanoma	0.000144	0.00143	CcSEcCtD
Gemcitabine—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000143	0.00143	CcSEcCtD
Gemcitabine—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000143	0.00143	CcSEcCtD
Gemcitabine—Leukopenia—Dactinomycin—melanoma	0.000143	0.00142	CcSEcCtD
Gemcitabine—Alanine aminotransferase increased—Docetaxel—melanoma	0.00014	0.0014	CcSEcCtD
Gemcitabine—Oedema—Bleomycin—melanoma	0.00014	0.00139	CcSEcCtD
Gemcitabine—Anaphylactic shock—Bleomycin—melanoma	0.00014	0.00139	CcSEcCtD
Gemcitabine—Back pain—Temozolomide—melanoma	0.000139	0.00139	CcSEcCtD
Gemcitabine—Infection—Bleomycin—melanoma	0.000139	0.00138	CcSEcCtD
Gemcitabine—Anaemia—Carmustine—melanoma	0.000138	0.00137	CcSEcCtD
Gemcitabine—Nausea—Vemurafenib—melanoma	0.000137	0.00136	CcSEcCtD
Gemcitabine—Thrombocytopenia—Bleomycin—melanoma	0.000137	0.00136	CcSEcCtD
Gemcitabine—Myalgia—Dactinomycin—melanoma	0.000136	0.00135	CcSEcCtD
Gemcitabine—Bronchospasm—Docetaxel—melanoma	0.000135	0.00135	CcSEcCtD
Gemcitabine—Discomfort—Dactinomycin—melanoma	0.000134	0.00134	CcSEcCtD
Gemcitabine—Ill-defined disorder—Temozolomide—melanoma	0.000134	0.00133	CcSEcCtD
Gemcitabine—Leukopenia—Carmustine—melanoma	0.000134	0.00133	CcSEcCtD
Gemcitabine—Anaemia—Temozolomide—melanoma	0.000133	0.00133	CcSEcCtD
Gemcitabine—Anorexia—Bleomycin—melanoma	0.000133	0.00133	CcSEcCtD
Gemcitabine—Pancytopenia—Docetaxel—melanoma	0.000131	0.0013	CcSEcCtD
Gemcitabine—Hypotension—Bleomycin—melanoma	0.00013	0.0013	CcSEcCtD
Gemcitabine—Oedema—Dactinomycin—melanoma	0.00013	0.0013	CcSEcCtD
Gemcitabine—Malaise—Temozolomide—melanoma	0.00013	0.0013	CcSEcCtD
Gemcitabine—Infection—Dactinomycin—melanoma	0.000129	0.00129	CcSEcCtD
Gemcitabine—Leukopenia—Temozolomide—melanoma	0.000129	0.00129	CcSEcCtD
Gemcitabine—Hypertension—Carmustine—melanoma	0.000129	0.00128	CcSEcCtD
Gemcitabine—Neutropenia—Docetaxel—melanoma	0.000129	0.00128	CcSEcCtD
Gemcitabine—Thrombocytopenia—Dactinomycin—melanoma	0.000127	0.00127	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000127	0.00127	CcSEcCtD
Gemcitabine—Chest pain—Carmustine—melanoma	0.000127	0.00127	CcSEcCtD
Gemcitabine—Myalgia—Carmustine—melanoma	0.000127	0.00127	CcSEcCtD
Gemcitabine—Cough—Temozolomide—melanoma	0.000126	0.00125	CcSEcCtD
Gemcitabine—Paraesthesia—Bleomycin—melanoma	0.000125	0.00125	CcSEcCtD
Gemcitabine—Hypertension—Temozolomide—melanoma	0.000125	0.00124	CcSEcCtD
Gemcitabine—Dyspnoea—Bleomycin—melanoma	0.000124	0.00124	CcSEcCtD
Gemcitabine—Anorexia—Dactinomycin—melanoma	0.000124	0.00124	CcSEcCtD
Gemcitabine—Pneumonia—Docetaxel—melanoma	0.000123	0.00123	CcSEcCtD
Gemcitabine—Myalgia—Temozolomide—melanoma	0.000123	0.00122	CcSEcCtD
Gemcitabine—Arthralgia—Temozolomide—melanoma	0.000123	0.00122	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000122	0.00122	CcSEcCtD
Gemcitabine—Oedema—Carmustine—melanoma	0.000122	0.00121	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000122	0.00121	CcSEcCtD
Gemcitabine—Discomfort—Temozolomide—melanoma	0.000121	0.00121	CcSEcCtD
Gemcitabine—Decreased appetite—Bleomycin—melanoma	0.000121	0.00121	CcSEcCtD
Gemcitabine—ABCB1—mammalian vulva—melanoma	0.000121	0.00431	CbGeAlD
Gemcitabine—Infection—Carmustine—melanoma	0.000121	0.00121	CcSEcCtD
Gemcitabine—Acute coronary syndrome—Docetaxel—melanoma	0.000121	0.00121	CcSEcCtD
Gemcitabine—Renal failure—Docetaxel—melanoma	0.000121	0.0012	CcSEcCtD
Gemcitabine—Myocardial infarction—Docetaxel—melanoma	0.00012	0.0012	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Docetaxel—melanoma	0.00012	0.0012	CcSEcCtD
Gemcitabine—Stomatitis—Docetaxel—melanoma	0.00012	0.00119	CcSEcCtD
Gemcitabine—Pain—Bleomycin—melanoma	0.000119	0.00119	CcSEcCtD
Gemcitabine—Thrombocytopenia—Carmustine—melanoma	0.000119	0.00119	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000119	0.00118	CcSEcCtD
Gemcitabine—Anaphylactic shock—Temozolomide—melanoma	0.000118	0.00117	CcSEcCtD
Gemcitabine—Oedema—Temozolomide—melanoma	0.000118	0.00117	CcSEcCtD
Gemcitabine—Infection—Temozolomide—melanoma	0.000117	0.00117	CcSEcCtD
Gemcitabine—Anorexia—Carmustine—melanoma	0.000116	0.00116	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Docetaxel—melanoma	0.000116	0.00116	CcSEcCtD
Gemcitabine—Nervous system disorder—Temozolomide—melanoma	0.000115	0.00115	CcSEcCtD
Gemcitabine—Thrombocytopenia—Temozolomide—melanoma	0.000115	0.00115	CcSEcCtD
Gemcitabine—Feeling abnormal—Bleomycin—melanoma	0.000115	0.00115	CcSEcCtD
Gemcitabine—Agranulocytosis—Docetaxel—melanoma	0.000115	0.00114	CcSEcCtD
Gemcitabine—Skin disorder—Temozolomide—melanoma	0.000114	0.00114	CcSEcCtD
Gemcitabine—Hypotension—Carmustine—melanoma	0.000114	0.00113	CcSEcCtD
Gemcitabine—Hyperhidrosis—Temozolomide—melanoma	0.000114	0.00113	CcSEcCtD
Gemcitabine—Decreased appetite—Dactinomycin—melanoma	0.000113	0.00113	CcSEcCtD
Gemcitabine—Fatigue—Dactinomycin—melanoma	0.000112	0.00112	CcSEcCtD
Gemcitabine—Anorexia—Temozolomide—melanoma	0.000112	0.00112	CcSEcCtD
Gemcitabine—Pain—Dactinomycin—melanoma	0.000111	0.00111	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Carmustine—melanoma	0.000111	0.00111	CcSEcCtD
Gemcitabine—Haemoglobin—Docetaxel—melanoma	0.000111	0.0011	CcSEcCtD
Gemcitabine—Rhinitis—Docetaxel—melanoma	0.00011	0.0011	CcSEcCtD
Gemcitabine—Body temperature increased—Bleomycin—melanoma	0.00011	0.0011	CcSEcCtD
Gemcitabine—Haemorrhage—Docetaxel—melanoma	0.00011	0.0011	CcSEcCtD
Gemcitabine—Insomnia—Carmustine—melanoma	0.00011	0.0011	CcSEcCtD
Gemcitabine—Paraesthesia—Carmustine—melanoma	0.000109	0.00109	CcSEcCtD
Gemcitabine—Pharyngitis—Docetaxel—melanoma	0.000109	0.00109	CcSEcCtD
Gemcitabine—Urinary tract disorder—Docetaxel—melanoma	0.000109	0.00108	CcSEcCtD
Gemcitabine—Dyspnoea—Carmustine—melanoma	0.000109	0.00108	CcSEcCtD
Gemcitabine—Oedema peripheral—Docetaxel—melanoma	0.000109	0.00108	CcSEcCtD
Gemcitabine—Somnolence—Carmustine—melanoma	0.000108	0.00108	CcSEcCtD
Gemcitabine—Connective tissue disorder—Docetaxel—melanoma	0.000108	0.00108	CcSEcCtD
Gemcitabine—Urethral disorder—Docetaxel—melanoma	0.000108	0.00108	CcSEcCtD
Gemcitabine—Feeling abnormal—Dactinomycin—melanoma	0.000107	0.00107	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000107	0.00107	CcSEcCtD
Gemcitabine—Insomnia—Temozolomide—melanoma	0.000106	0.00106	CcSEcCtD
Gemcitabine—Decreased appetite—Carmustine—melanoma	0.000106	0.00106	CcSEcCtD
Gemcitabine—Paraesthesia—Temozolomide—melanoma	0.000106	0.00105	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Carmustine—melanoma	0.000105	0.00105	CcSEcCtD
Gemcitabine—Dyspnoea—Temozolomide—melanoma	0.000105	0.00105	CcSEcCtD
Gemcitabine—Somnolence—Temozolomide—melanoma	0.000105	0.00104	CcSEcCtD
Gemcitabine—Erythema multiforme—Docetaxel—melanoma	0.000104	0.00104	CcSEcCtD
Gemcitabine—Constipation—Carmustine—melanoma	0.000104	0.00104	CcSEcCtD
Gemcitabine—Pain—Carmustine—melanoma	0.000104	0.00104	CcSEcCtD
Gemcitabine—Body temperature increased—Dactinomycin—melanoma	0.000103	0.00103	CcSEcCtD
Gemcitabine—Decreased appetite—Temozolomide—melanoma	0.000102	0.00102	CcSEcCtD
Gemcitabine—Cardiac disorder—Docetaxel—melanoma	0.000102	0.00102	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Temozolomide—melanoma	0.000102	0.00101	CcSEcCtD
Gemcitabine—Fatigue—Temozolomide—melanoma	0.000101	0.00101	CcSEcCtD
Gemcitabine—Constipation—Temozolomide—melanoma	0.000101	0.001	CcSEcCtD
Gemcitabine—Pain—Temozolomide—melanoma	0.000101	0.001	CcSEcCtD
Gemcitabine—Feeling abnormal—Carmustine—melanoma	0.0001	0.001	CcSEcCtD
Gemcitabine—Asthenia—Bleomycin—melanoma	0.0001	0.000998	CcSEcCtD
Gemcitabine—Angiopathy—Docetaxel—melanoma	9.99e-05	0.000996	CcSEcCtD
Gemcitabine—Immune system disorder—Docetaxel—melanoma	9.95e-05	0.000992	CcSEcCtD
Gemcitabine—Mediastinal disorder—Docetaxel—melanoma	9.93e-05	0.00099	CcSEcCtD
Gemcitabine—Chills—Docetaxel—melanoma	9.88e-05	0.000985	CcSEcCtD
Gemcitabine—Pruritus—Bleomycin—melanoma	9.87e-05	0.000984	CcSEcCtD
Gemcitabine—Arrhythmia—Docetaxel—melanoma	9.84e-05	0.000981	CcSEcCtD
Gemcitabine—Alopecia—Docetaxel—melanoma	9.73e-05	0.00097	CcSEcCtD
Gemcitabine—Feeling abnormal—Temozolomide—melanoma	9.7e-05	0.000967	CcSEcCtD
Gemcitabine—Body temperature increased—Carmustine—melanoma	9.63e-05	0.00096	CcSEcCtD
Gemcitabine—Erythema—Docetaxel—melanoma	9.59e-05	0.000956	CcSEcCtD
Gemcitabine—Asthenia—Dactinomycin—melanoma	9.34e-05	0.000931	CcSEcCtD
Gemcitabine—Body temperature increased—Temozolomide—melanoma	9.3e-05	0.000927	CcSEcCtD
Gemcitabine—Back pain—Docetaxel—melanoma	9.28e-05	0.000925	CcSEcCtD
Gemcitabine—Diarrhoea—Dactinomycin—melanoma	8.9e-05	0.000888	CcSEcCtD
Gemcitabine—Vomiting—Bleomycin—melanoma	8.87e-05	0.000884	CcSEcCtD
Gemcitabine—Anaemia—Docetaxel—melanoma	8.86e-05	0.000884	CcSEcCtD
Gemcitabine—Rash—Bleomycin—melanoma	8.8e-05	0.000877	CcSEcCtD
Gemcitabine—Dermatitis—Bleomycin—melanoma	8.79e-05	0.000876	CcSEcCtD
Gemcitabine—Asthenia—Carmustine—melanoma	8.74e-05	0.000871	CcSEcCtD
Gemcitabine—ABCB1—head—melanoma	8.66e-05	0.00309	CbGeAlD
Gemcitabine—Leukopenia—Docetaxel—melanoma	8.58e-05	0.000856	CcSEcCtD
Gemcitabine—Asthenia—Temozolomide—melanoma	8.44e-05	0.000842	CcSEcCtD
Gemcitabine—Cough—Docetaxel—melanoma	8.37e-05	0.000834	CcSEcCtD
Gemcitabine—Diarrhoea—Carmustine—melanoma	8.33e-05	0.000831	CcSEcCtD
Gemcitabine—Pruritus—Temozolomide—melanoma	8.33e-05	0.00083	CcSEcCtD
Gemcitabine—Nausea—Bleomycin—melanoma	8.29e-05	0.000826	CcSEcCtD
Gemcitabine—Hypertension—Docetaxel—melanoma	8.28e-05	0.000825	CcSEcCtD
Gemcitabine—Vomiting—Dactinomycin—melanoma	8.27e-05	0.000825	CcSEcCtD
Gemcitabine—Rash—Dactinomycin—melanoma	8.2e-05	0.000818	CcSEcCtD
Gemcitabine—Chest pain—Docetaxel—melanoma	8.16e-05	0.000814	CcSEcCtD
Gemcitabine—Myalgia—Docetaxel—melanoma	8.16e-05	0.000814	CcSEcCtD
Gemcitabine—Arthralgia—Docetaxel—melanoma	8.16e-05	0.000814	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	8.11e-05	0.000808	CcSEcCtD
Gemcitabine—Diarrhoea—Temozolomide—melanoma	8.05e-05	0.000803	CcSEcCtD
Gemcitabine—Anaphylactic shock—Docetaxel—melanoma	7.83e-05	0.00078	CcSEcCtD
Gemcitabine—Oedema—Docetaxel—melanoma	7.83e-05	0.00078	CcSEcCtD
Gemcitabine—Infection—Docetaxel—melanoma	7.78e-05	0.000775	CcSEcCtD
Gemcitabine—Vomiting—Carmustine—melanoma	7.74e-05	0.000772	CcSEcCtD
Gemcitabine—Nausea—Dactinomycin—melanoma	7.73e-05	0.00077	CcSEcCtD
Gemcitabine—Rash—Carmustine—melanoma	7.68e-05	0.000765	CcSEcCtD
Gemcitabine—Nervous system disorder—Docetaxel—melanoma	7.68e-05	0.000765	CcSEcCtD
Gemcitabine—Dermatitis—Carmustine—melanoma	7.67e-05	0.000765	CcSEcCtD
Gemcitabine—Thrombocytopenia—Docetaxel—melanoma	7.66e-05	0.000764	CcSEcCtD
Gemcitabine—Headache—Carmustine—melanoma	7.63e-05	0.000761	CcSEcCtD
Gemcitabine—Skin disorder—Docetaxel—melanoma	7.6e-05	0.000758	CcSEcCtD
Gemcitabine—Vomiting—Temozolomide—melanoma	7.48e-05	0.000746	CcSEcCtD
Gemcitabine—Anorexia—Docetaxel—melanoma	7.46e-05	0.000744	CcSEcCtD
Gemcitabine—Rash—Temozolomide—melanoma	7.42e-05	0.00074	CcSEcCtD
Gemcitabine—Dermatitis—Temozolomide—melanoma	7.41e-05	0.000739	CcSEcCtD
Gemcitabine—Headache—Temozolomide—melanoma	7.37e-05	0.000735	CcSEcCtD
Gemcitabine—Hypotension—Docetaxel—melanoma	7.31e-05	0.000729	CcSEcCtD
Gemcitabine—Nausea—Carmustine—melanoma	7.23e-05	0.000721	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Docetaxel—melanoma	7.13e-05	0.000711	CcSEcCtD
Gemcitabine—Insomnia—Docetaxel—melanoma	7.08e-05	0.000706	CcSEcCtD
Gemcitabine—Paraesthesia—Docetaxel—melanoma	7.03e-05	0.000701	CcSEcCtD
Gemcitabine—Nausea—Temozolomide—melanoma	6.99e-05	0.000697	CcSEcCtD
Gemcitabine—Dyspnoea—Docetaxel—melanoma	6.98e-05	0.000696	CcSEcCtD
Gemcitabine—Somnolence—Docetaxel—melanoma	6.96e-05	0.000694	CcSEcCtD
Gemcitabine—Decreased appetite—Docetaxel—melanoma	6.8e-05	0.000678	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Docetaxel—melanoma	6.76e-05	0.000674	CcSEcCtD
Gemcitabine—Fatigue—Docetaxel—melanoma	6.75e-05	0.000673	CcSEcCtD
Gemcitabine—Pain—Docetaxel—melanoma	6.69e-05	0.000667	CcSEcCtD
Gemcitabine—Constipation—Docetaxel—melanoma	6.69e-05	0.000667	CcSEcCtD
Gemcitabine—Feeling abnormal—Docetaxel—melanoma	6.45e-05	0.000643	CcSEcCtD
Gemcitabine—Body temperature increased—Docetaxel—melanoma	6.19e-05	0.000617	CcSEcCtD
Gemcitabine—ABCB1—lymph node—melanoma	6.06e-05	0.00216	CbGeAlD
Gemcitabine—Asthenia—Docetaxel—melanoma	5.62e-05	0.00056	CcSEcCtD
Gemcitabine—Pruritus—Docetaxel—melanoma	5.54e-05	0.000552	CcSEcCtD
Gemcitabine—Diarrhoea—Docetaxel—melanoma	5.36e-05	0.000534	CcSEcCtD
Gemcitabine—Vomiting—Docetaxel—melanoma	4.98e-05	0.000496	CcSEcCtD
Gemcitabine—Rash—Docetaxel—melanoma	4.93e-05	0.000492	CcSEcCtD
Gemcitabine—Dermatitis—Docetaxel—melanoma	4.93e-05	0.000491	CcSEcCtD
Gemcitabine—Headache—Docetaxel—melanoma	4.9e-05	0.000489	CcSEcCtD
Gemcitabine—Nausea—Docetaxel—melanoma	4.65e-05	0.000463	CcSEcCtD
Gemcitabine—TYMS—Cell Cycle—CDK2—melanoma	1.27e-05	0.000129	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CCND1—melanoma	1.27e-05	0.000129	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—SLC5A5—melanoma	1.26e-05	0.000128	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—ATM—melanoma	1.26e-05	0.000128	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDK4—melanoma	1.25e-05	0.000128	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CYP1B1—melanoma	1.25e-05	0.000127	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—ABCB1—melanoma	1.25e-05	0.000127	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CYP1B1—melanoma	1.24e-05	0.000126	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CDKN1B—melanoma	1.24e-05	0.000126	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CDKN1B—melanoma	1.23e-05	0.000126	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.23e-05	0.000125	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CDKN1A—melanoma	1.23e-05	0.000125	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.22e-05	0.000124	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—RB1—melanoma	1.22e-05	0.000124	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GNAQ—melanoma	1.22e-05	0.000124	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CD44—melanoma	1.22e-05	0.000124	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—ATM—melanoma	1.21e-05	0.000123	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—CXCL8—melanoma	1.2e-05	0.000122	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDK4—melanoma	1.2e-05	0.000122	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CDKN1B—melanoma	1.19e-05	0.000121	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PIK3CG—melanoma	1.19e-05	0.000121	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CCND1—melanoma	1.18e-05	0.00012	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.18e-05	0.00012	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CCND1—melanoma	1.18e-05	0.00012	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—RB1—melanoma	1.17e-05	0.000119	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CYP1B1—melanoma	1.17e-05	0.000119	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—VCAN—melanoma	1.15e-05	0.000117	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—CASP3—melanoma	1.15e-05	0.000117	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IL2—melanoma	1.15e-05	0.000117	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PRKCA—melanoma	1.15e-05	0.000117	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PPARG—melanoma	1.15e-05	0.000117	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CDKN1A—melanoma	1.14e-05	0.000117	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	1.14e-05	0.000116	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—ERCC2—melanoma	1.14e-05	0.000116	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CDKN1A—melanoma	1.14e-05	0.000116	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CCND1—melanoma	1.14e-05	0.000116	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—TP53—melanoma	1.13e-05	0.000115	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—melanoma	1.13e-05	0.000115	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CDKN1A—melanoma	1.1e-05	0.000112	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—MAPK3—melanoma	1.09e-05	0.000111	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—RB1—melanoma	1.09e-05	0.000111	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—MAPK3—melanoma	1.08e-05	0.00011	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	1.07e-05	0.000109	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDKN2A—melanoma	1.07e-05	0.000109	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—MYC—melanoma	1.06e-05	0.000108	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—MYC—melanoma	1.06e-05	0.000107	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	1.05e-05	0.000107	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—MAPK3—melanoma	1.05e-05	0.000107	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—RB1—melanoma	1.04e-05	0.000106	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PIK3CD—melanoma	1.04e-05	0.000106	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1.04e-05	0.000106	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	1.04e-05	0.000106	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—MAPK1—melanoma	1.04e-05	0.000106	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—IL6—melanoma	1.04e-05	0.000106	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—MAPK1—melanoma	1.03e-05	0.000105	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—ALB—melanoma	1.03e-05	0.000105	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	1.03e-05	0.000105	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—ABCB1—melanoma	1.03e-05	0.000105	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDKN2A—melanoma	1.03e-05	0.000105	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—ABCB1—melanoma	1.02e-05	0.000104	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—MYC—melanoma	1.02e-05	0.000104	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	1.01e-05	0.000103	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic M-M/G1 phases—MAPK3—melanoma	9.98e-06	0.000102	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—MAPK1—melanoma	9.97e-06	0.000102	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	9.96e-06	0.000101	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	9.9e-06	0.000101	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ACER3—melanoma	9.84e-06	0.0001	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—VEGFA—melanoma	9.76e-06	9.94e-05	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—MAPK3—melanoma	9.76e-06	9.94e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—melanoma	9.73e-06	9.9e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CYP17A1—melanoma	9.72e-06	9.9e-05	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—MAPK3—melanoma	9.7e-06	9.88e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—ABCB1—melanoma	9.61e-06	9.78e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDKN2A—melanoma	9.58e-06	9.75e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	9.54e-06	9.71e-05	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic M-M/G1 phases—MAPK1—melanoma	9.5e-06	9.67e-05	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—MYC—melanoma	9.49e-06	9.66e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDKN1B—melanoma	9.49e-06	9.66e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PRKCA—melanoma	9.46e-06	9.63e-05	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—MYC—melanoma	9.43e-06	9.61e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PRKCA—melanoma	9.4e-06	9.58e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—ERCC2—melanoma	9.38e-06	9.55e-05	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—MAPK3—melanoma	9.37e-06	9.54e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—ERCC2—melanoma	9.33e-06	9.5e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—MDM2—melanoma	9.29e-06	9.46e-05	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—MAPK1—melanoma	9.29e-06	9.45e-05	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—MAPK1—melanoma	9.23e-06	9.4e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GNA11—melanoma	9.18e-06	9.35e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDKN2A—melanoma	9.18e-06	9.35e-05	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—MYC—melanoma	9.11e-06	9.28e-05	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PIK3CB—melanoma	9.1e-06	9.26e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDKN1B—melanoma	9.09e-06	9.26e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	9.06e-06	9.22e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CCND1—melanoma	9.05e-06	9.22e-05	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PTGS2—melanoma	9.02e-06	9.18e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—UGT2B10—melanoma	9e-06	9.16e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PIK3CG—melanoma	9e-06	9.16e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—FASN—melanoma	8.98e-06	9.15e-05	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PIK3CA—melanoma	8.98e-06	9.14e-05	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—MAPK1—melanoma	8.91e-06	9.08e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—MDM2—melanoma	8.9e-06	9.06e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PRKCA—melanoma	8.84e-06	9e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—SLC5A5—melanoma	8.84e-06	9e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—ERCC2—melanoma	8.77e-06	8.93e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDKN1A—melanoma	8.76e-06	8.92e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PPARG—melanoma	8.69e-06	8.84e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CCND1—melanoma	8.67e-06	8.83e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—melanoma	8.6e-06	8.75e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	8.56e-06	8.72e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CD44—melanoma	8.53e-06	8.69e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GNAQ—melanoma	8.53e-06	8.69e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDKN1B—melanoma	8.48e-06	8.64e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDKN1A—melanoma	8.39e-06	8.54e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—TNF—melanoma	8.37e-06	8.52e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—HS3ST5—melanoma	8.37e-06	8.52e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CYP1B1—melanoma	8.18e-06	8.33e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDKN1B—melanoma	8.13e-06	8.28e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CCND1—melanoma	8.09e-06	8.24e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—melanoma	8.06e-06	8.2e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—melanoma	7.96e-06	8.11e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PIK3CD—melanoma	7.91e-06	8.06e-05	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PTEN—melanoma	7.86e-06	8.01e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDKN1A—melanoma	7.83e-06	7.97e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—ALB—melanoma	7.81e-06	7.95e-05	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—TP53—melanoma	7.79e-06	7.94e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CCND1—melanoma	7.75e-06	7.9e-05	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—TP53—melanoma	7.75e-06	7.89e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	7.5e-06	7.64e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDKN1A—melanoma	7.5e-06	7.64e-05	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—TP53—melanoma	7.48e-06	7.62e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—MAPK3—melanoma	7.47e-06	7.6e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PIK3CG—melanoma	7.41e-06	7.55e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	7.38e-06	7.51e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PIK3CG—melanoma	7.37e-06	7.5e-05	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—AKT1—melanoma	7.33e-06	7.47e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—MYC—melanoma	7.26e-06	7.39e-05	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—AKT1—melanoma	7.19e-06	7.33e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PPARG—melanoma	7.15e-06	7.28e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—MAPK3—melanoma	7.15e-06	7.28e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	7.13e-06	7.26e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PPARG—melanoma	7.11e-06	7.24e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—MAPK1—melanoma	7.1e-06	7.23e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—MYC—melanoma	6.96e-06	7.08e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PIK3CG—melanoma	6.93e-06	7.05e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PIK3CB—melanoma	6.9e-06	7.02e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PTGS2—melanoma	6.83e-06	6.96e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—MAPK1—melanoma	6.81e-06	6.93e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	6.78e-06	6.91e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ABCB1—melanoma	6.74e-06	6.86e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PPARG—melanoma	6.68e-06	6.81e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—MAPK3—melanoma	6.67e-06	6.8e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PIK3CD—melanoma	6.51e-06	6.63e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—MYC—melanoma	6.49e-06	6.61e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PIK3CD—melanoma	6.48e-06	6.59e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	6.44e-06	6.56e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—ALB—melanoma	6.43e-06	6.55e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—MAPK3—melanoma	6.39e-06	6.51e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—ALB—melanoma	6.39e-06	6.51e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—MAPK1—melanoma	6.35e-06	6.47e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	6.35e-06	6.46e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PLCB4—melanoma	6.34e-06	6.46e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	6.26e-06	6.37e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—MYC—melanoma	6.22e-06	6.33e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PRKCA—melanoma	6.2e-06	6.31e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ERCC2—melanoma	6.15e-06	6.26e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	6.12e-06	6.23e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PIK3CD—melanoma	6.09e-06	6.2e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—MAPK1—melanoma	6.08e-06	6.2e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—ALB—melanoma	6.01e-06	6.12e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SLC6A11—melanoma	5.96e-06	6.07e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PIP4K2A—melanoma	5.96e-06	6.07e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PTEN—melanoma	5.96e-06	6.07e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	5.82e-06	5.93e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—MTAP—melanoma	5.8e-06	5.9e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	5.79e-06	5.9e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	5.68e-06	5.78e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PIK3CB—melanoma	5.68e-06	5.78e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PIK3CB—melanoma	5.64e-06	5.75e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PTGS2—melanoma	5.63e-06	5.73e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PTGS2—melanoma	5.59e-06	5.69e-05	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PIK3CA—melanoma	5.55e-06	5.65e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	5.53e-06	5.63e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	5.47e-06	5.57e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	5.35e-06	5.44e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	5.34e-06	5.43e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—TP53—melanoma	5.33e-06	5.43e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	5.31e-06	5.41e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PIK3CB—melanoma	5.31e-06	5.4e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PTGS2—melanoma	5.26e-06	5.35e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PHGDH—melanoma	5.17e-06	5.26e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—LUM—melanoma	5.17e-06	5.26e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—TP53—melanoma	5.11e-06	5.2e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—HPSE—melanoma	5.07e-06	5.16e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CUBN—melanoma	4.98e-06	5.07e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PTEN—melanoma	4.91e-06	5e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PTEN—melanoma	4.88e-06	4.97e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PIK3CG—melanoma	4.86e-06	4.94e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	4.82e-06	4.91e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SDHD—melanoma	4.81e-06	4.89e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CSPG4—melanoma	4.81e-06	4.89e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—BSG—melanoma	4.81e-06	4.89e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PPARG—melanoma	4.69e-06	4.77e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GPAM—melanoma	4.65e-06	4.74e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PTEN—melanoma	4.59e-06	4.67e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	4.56e-06	4.64e-05	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—AKT1—melanoma	4.53e-06	4.61e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	4.43e-06	4.51e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	4.34e-06	4.42e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	4.34e-06	4.42e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PIK3CD—melanoma	4.27e-06	4.35e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ALB—melanoma	4.21e-06	4.29e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PIK3CA—melanoma	4.2e-06	4.28e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	4.13e-06	4.21e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	4.1e-06	4.17e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PLA2G6—melanoma	3.96e-06	4.03e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	3.76e-06	3.83e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PIK3CB—melanoma	3.72e-06	3.79e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PTGS2—melanoma	3.69e-06	3.75e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	3.64e-06	3.71e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—VCAN—melanoma	3.55e-06	3.62e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PIK3CA—melanoma	3.46e-06	3.52e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PIK3CA—melanoma	3.44e-06	3.5e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—AKT1—melanoma	3.43e-06	3.5e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PIK3CA—melanoma	3.23e-06	3.29e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PTEN—melanoma	3.22e-06	3.27e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	3.07e-06	3.13e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP17A1—melanoma	3e-06	3.05e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GNA11—melanoma	2.83e-06	2.88e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—AKT1—melanoma	2.83e-06	2.88e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—AKT1—melanoma	2.81e-06	2.86e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	2.78e-06	2.83e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—FASN—melanoma	2.77e-06	2.82e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SLC5A5—melanoma	2.73e-06	2.78e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—AKT1—melanoma	2.64e-06	2.69e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CD44—melanoma	2.63e-06	2.68e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GNAQ—melanoma	2.63e-06	2.68e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP1B1—melanoma	2.52e-06	2.57e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PIK3CA—melanoma	2.27e-06	2.31e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PRKCA—melanoma	1.91e-06	1.95e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ERCC2—melanoma	1.9e-06	1.93e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—AKT1—melanoma	1.85e-06	1.89e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PIK3CG—melanoma	1.5e-06	1.53e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PPARG—melanoma	1.45e-06	1.47e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PIK3CD—melanoma	1.32e-06	1.34e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ALB—melanoma	1.3e-06	1.32e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PIK3CB—melanoma	1.15e-06	1.17e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PTGS2—melanoma	1.14e-06	1.16e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PTEN—melanoma	9.92e-07	1.01e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PIK3CA—melanoma	7e-07	7.13e-06	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—AKT1—melanoma	5.72e-07	5.82e-06	CbGpPWpGaD
